Robert Iannone
Director Técnico/Científico/I+D en JAZZ PHARMACEUTICALS PLC .
Fortuna: 6 M $ al 30/04/2024
Cargos activos de Robert Iannone
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Director Técnico/Científico/I+D | 29/05/2019 | - |
| ITEOS THERAPEUTICS, INC. | Director/Miembro de la Junta | 03/04/2021 | - |
| Independent Dir/Board Member | 03/04/2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Miembro de la Junta | 20/06/2023 | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Director Técnico/Científico/I+D | 01/05/2019 | - |
Historial de carrera de Robert Iannone
Antiguos cargos conocidos de Robert Iannone.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Miembro de la Junta | 21/01/2020 | 03/05/2023 |
| Independent Dir/Board Member | 21/01/2020 | 03/05/2023 | |
| IMMUNOMEDICS, INC. | Director Técnico/Científico/I+D | 09/04/2018 | 28/05/2019 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/07/2014 | 01/04/2018 |
| MERCK & CO., INC. | Director/Miembro de la Junta | 01/03/2008 | 01/07/2014 |
| Corporate Officer/Principal | 01/03/2008 | 01/07/2014 | |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 01/01/2001 | 01/01/2012 |
Formación de Robert Iannone.
| University of Pennsylvania Medical Center | Graduate Degree |
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 9 |
| Reino Unido | 3 |
| Irlanda | 2 |
Operativa
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Robert Iannone
- Experiencia
